基本情報
- 標準SMILES
CCCC(=O)Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1OC(=O)CCC- InChIKey
CJGYSWNGNKCJSB-YVLZZHOMSA-N- 分子式
- C18H24N5O8P
- 平均分子量
- 469.4 g/mol
- 単同位体質量
- 469.13624974
名称と識別子
- 優先名称
- Bucladesine
- IUPAC
- [(4aR,6R,7R,7aR)-6-[6-(butanoylamino)purin-9-yl]-2-hydroxy-2-oxo-4a,6,7,7a-tetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-7-yl] butanoate
- 現地名
- ブクラデシン
- 英語名
- Bucladesine
- 分子式
- C18H24N5O8P
- 分子量
- 469.39
名称と別名
名称をさらに表示
データベース識別子
- CAS
362-74-3- PubChem CID
- 9687
- DTXSID
DTXSID1040459- ChEMBL
CHEMBL485980- ChEBI
CHEBI:50095- UNII
- 63X7MBT2LQ
- EC Number
- 206-649-8
- Nikkaji
- J33.134A
物性
構造計算による物性
- XLogP
- -0.5
- 極性表面積
- 164 Ų
- 水素結合供与体数
- 2
- 水素結合受容体数
- 11
- 回転可能結合数
- 8
- 重原子数
- 32
- 形式電荷
- 0
- 複雑度
- 759
実験および物理化学的性質
Collision Cross Section
215.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
210.36 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];214.52 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];214.45 Ų [M+K]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
物理化学的性質
- 比重(密度)
- 1.72 · 1.72±0.1 g/cm3(Predicted)
- 貯蔵温度
- -20 °C · -20°C Freezer
- 溶解性
- DMSO;メタノ
- 酸解離定数(Pka)
- 0.82 · 0.82±0.60(Predicted)
- 外見
- 個体
- 色
- 白い
安全と法規制
危険有害性情報
Other Safety Information
IMAP assessments - Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate: Environment tier I assessment;IMAP assessments - Adenosine, N-(1-oxobutyl)-, cyclic 3',5'-(hydrogen phosphate) 2'-butanoate: Human health tier I assessment
安全データ
- 注意喚起語
- 警告
- 危険有害性情報
- コード 危険有害性情報 危険有害性クラス 区分 注意喚起語 シンボル P コード H302
化学と産業
薬理情報
ATC Code
C - Cardiovascular system;C01 - Cardiac therapy;C01C - Cardiac stimulants excl. cardiac glycosides;C01CE - Phosphodiesterase inhibitors;C01CE04 - Bucladesine
QC - Cardiovascular system;QC01 - Cardiac therapy;QC01C - Cardiac stimulants excl. cardiac glycosides;QC01CE - Phosphodiesterase inhibitors;QC01CE04 - Bucladesine
応用分野
説明Bucladesine is a cyclic nucleotide derivative that mimics the action of endogenous CYCLIC AMP and is capable of permeating the cell membrane. It has vasodilator properties and is used as a cardiac stimulant. (From Merck Index, 11th ed)
使用Bucladesine is a cell permeable cAMP analog. The compound is used in a wide variety of research applications because it mimics cAMP and can induce normal physiological responses when added to cells in experimental conditions. cAMP is only able to elicit minimal responses in these situations. The neurite outgrowth instigated by bucladesine in cell cultures has been shown to be enhanced by nardosinone.
サプライヤー50 社
補足説明
定義ChEBI: Bucladesine is a 3',5'-cyclic purine nucleotide that is the 2'-butanoate ester and 6-N-butanoyl derivative of 3',5'-cyclic AMP. It has a role as an agonist, a vasodilator agent and a cardiotonic drug. It is a butyrate ester, a 3',5'-cyclic purine nucleotide and a member of butanamides. It is functionally related to a 3',5'-cyclic AMP.
関連反応
関連ノート
読み込み中…